In a mouse model of breast cancer, SEMA3A overexpression in 4T1 cancer cells decreased tumor volume to 61% and promoted the accumulation of M1-like (CD11b+Ly6G−lowMHCIIhigh) macrophages in the tumor compared to 4T1-control tumors [42]. The gene discussed is ITGAM; the disease is neoplasm.